{
  "signal_id": "SIG-2026-002",
  "observed_date": "2026-08-08",
  "category": "Regulation + Digital Health",
  "title": "FDA TEMPO participant page now lists Cadence Solutions and Dexcom",
  "what_changed": "FDA's current TEMPO participant table lists Cadence Solutions' HypertensionOS and Dexcom's Glucose Health Program, expanding the pilot beyond the initial announced participant.",
  "why_it_matters": "The pilot is moving from concept into a multi-product real-world test spanning hypertension and metabolic care, increasing the value of tracking participant selection criteria, outcomes, and operational models.",
  "affected_actors": [
    "FDA",
    "Cadence Solutions",
    "Dexcom",
    "ACCESS organizations",
    "clinicians"
  ],
  "decision_implication": "Monitor whether participant expansion reveals a repeatable regulatory-adoption pathway for technology-enabled chronic care.",
  "status": "Live / expanding",
  "evidence_class": "E5 — official federal source",
  "impact": 5,
  "immediacy": 5,
  "relevance": 5,
  "novelty": 5,
  "adoption_leverage": 5,
  "priority_score": 100,
  "sources": [
    "https://www.fda.gov/medical-devices/digital-health-center-excellence/participants-selected-tempo-digital-health-devices-pilot"
  ],
  "public_slug": "/signal/2026-08-08-tempo-cadence-dexcom/",
  "watch_conditions": [
    "New participant additions",
    "changes to intended uses",
    "safety/RWD findings."
  ],
  "last_verified": "2026-08-08",
  "version": "1.0"
}